Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study

Research output: Contribution to journalJournal articleResearchpeer-review


  • Ditte Sloth Moller
  • Tine Bjørn Nielsen
  • Carsten Brink
  • Lone Hoffmann
  • Christina Maria Lutz
  • Mikkel Drogemuller Lund
  • Olfred Hansen
  • Tine Schytte
  • Azza Ahmed Khalil
  • Marianne Marquard Knap
  • Christa Haugaard Nyhus
  • Wiviann Ottosson
  • Patrik Sibolt
  • Svetlana Borissova
  • Josipovic, Mirjana
  • Persson, Gitte
  • Ane Lindegaard Appelt
Original languageEnglish
JournalRadiotherapy & Oncology
Issue number2
Pages (from-to)311-317
Publication statusPublished - Aug 2017

    Research areas

  • NSCLC, Dose-escalation, Randomized phase-III trial

Number of downloads are based on statistics from Google Scholar and www.ku.dk

No data available

ID: 184386819